Skip to main content

Market Overview

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX)

15.99 -0.29 (-1.78%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
Pre-Market
EPS:
REV:




Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:
-0.26
6.102M



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.24
4.823M
-0.27
8.89M
-0.36
19.059M
-33.33%
114.39%
Q4 2020
Pre-Market
EPS:
REV:
-0.02
39.725M
-0.25
17.52M
-0.34
4.016M
-36%
-77.08%
Q3 2020
Pre-Market
EPS:
REV:
-0.34
1.775M
-0.25
3.6M
-0.26
6.102M
-4%
69.5%
Q2 2020
Pre-Market
EPS:
REV:
-0.34
1.448M
-0.25
2.26M
-0.24
2.871M
4%
27.04%
Q1 2020
Pre-Market
EPS:
REV:
-0.28
5.887M
-0.25
4.29M
-0.24
4.823M
4%
12.42%
Q4 2019
Pre-Market
EPS:
REV:
-0.25
2.729M
-0.26
9.88M
-0.02
39.725M
92.31%
302.07%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!